Drugs / Albis Tab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01397240 | Jul 2011 → Jan 2012 | — | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2014-12-05 | Daewoong Pharmaceutical Co. LTD. | Regulatory Daewoong Pharmaceutical’s Ursa completed registration in Georgia daewoong.co.kr ↗
The 6 products that completed registration are ‘Composite Urusa Soft Cap’, ‘Daewoong Urusa Soft Cap’, ‘EZN 6 Pro Soft Cap’, ‘Bearse Tab’, ‘Gomcephin Daewoong INJ 1000mg’, and ‘Albis Tab’, which will be exported from the beginning of 2015. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2014-12-05 | Daewoong Pharmaceutical Co. LTD. | Daewoong Pharmaceutical’s Ursa completed registration in Georgia daewoong.co.kr ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Albis Tab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01397240 ↗ |